Unmet Challenges in Immune-Mediated Hepatobiliary Diseases

Clinical Reviews in Allergy and Immunology

Volumn 48, Issue 2-3, 2015, Pages 127-131

  Beuers, Ulrich ^a   Gershwin, M Eric ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune hepatitis; Biologics; Environmental factors; Genetics; Primary biliary cirrhosis; Progressive sclerosing cholangitis

Indexed keywords

AUTOIMMUNE DISEASES; BILIARY TRACT DISEASES; HUMAN; IMMUNOLOGY; LIVER DISEASES;

AUTOIMMUNE DISEASES; BILIARY TRACT DISEASES; HUMANS; LIVER DISEASES;

EID: 84937763288     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-015-8484-9     Document Type: Review

References (92)

1. Mackay IR, Burnet F (1963) Autoimmune Diseases. Charles C. Thomas, Springfield
2. Berrih-Aknin S (2014) Myasthenia Gravis: paradox versus paradigm in autoimmunity. J Autoimmun 52:1–28
3. Collin R, Dugas V, Chabot-Roy G, et al (2015) Autoimmunity and antibody affinity maturation are modulated by genetic variants on mouse chromosome 12. J Autoimmun
4. Cui Y, Sheng Y, Zhang X (2013) Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun 41:25–33
5. de Boer YS, van Gerven NM, Zwiers A et al (2014) Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology 147:443–452, e445
6. Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN (2015) Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 21:60–83
7. Hirschfield GM, Karlsen TH (2014) Genetic risks link autoimmune hepatitis to other autoimmune liver disease. Gastroenterology 147:270–273
8. Juran BD, Lazaridis KN (2014) Environmental factors in primary biliary cirrhosis. Semin Liver Dis 34:265–272
9. Kopec AK, Sullivan BP, Kassel KM, Joshi N, Luyendyk JP (2014) Toxicogenomic analysis reveals profibrogenic effects of trichloroethylene in autoimmune-mediated cholangitis in mice. Toxicol Sci 141:515–523
10. Lu Q (2013) The critical importance of epigenetics in autoimmunity. J Autoimmun 41:1–5
11. Lugli EB, Correia R, Fischer R et al (2015) Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis. Arthritis Res Ther 17:9
12. Wang L, Wang FS, Chang C, Gershwin ME (2014) Breach of tolerance: primary biliary cirrhosis. Semin Liver Dis 34:297–317
13. Yang W, Yao Y, Yang YQ et al (2014) Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Ralpha deleted mice. PLoS One 9:e105351
14. Zhang P, Zhao M, Liang G et al (2013) Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. J Autoimmun 41:17–24
15. Hirschfield GM, Gershwin ME (2013) The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 8:303–330
16. Agmon-Levin N, Arango MT, Kivity S et al (2014) Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. J Autoimmun 54:21–32
17. Castiella A, Zapata E, Lucena MI, Andrade RJ (2014) Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease. World J Hepatol 6:160–168
18. Chen RC, Naiyanetr P, Shu SA et al (2013) Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology 57:1498–1508
19. Coit P, Yalavarthi S, Ognenovski M, et al (2015) Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils. J Autoimmun
20. deLemos AS, Foureau DM, Jacobs C, Ahrens W, Russo MW, Bonkovsky HL (2014) Drug-induced liver injury with autoimmune features. Semin Liver Dis 34:194–204
21. Fan Y, Gualtierotti G, Tajima A et al (2014) Compromised central tolerance of ICA69 induces multiple organ autoimmunity. J Autoimmun 53:10–25
22. Katoh H, Zheng P, Liu Y (2013) FOXP3: genetic and epigenetic implications for autoimmunity. J Autoimmun 41:72–78
23. Leung PS, Wang J, Naiyanetr P et al (2013) Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun 41:79–86
24. Wang Q, Selmi C, Zhou X et al (2013) Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 41:140–145
25. Zhao M, Liu S, Luo S et al (2014) DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun 54:127–136
26. Adutler-Lieber S, Zaretsky I, Platzman I et al (2014) Engineering of synthetic cellular microenvironments: implications for immunity. J Autoimmun 54:100–111
27. Ando Y, Yang GX, Kenny TP et al (2013) Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse. J Autoimmun 41:111–119
28. Bowlus CL, Gershwin ME (2014) The diagnosis of primary biliary cirrhosis. Autoimmun Rev 13:441–444
29. Chang CH, Chen YC, Yu YH et al (2014) Innate immunity drives xenobiotic-induced murine autoimmune cholangitis. Clin Exp Immunol 177:373–380
30. Fuchs S, Aricha R, Reuveni D, Souroujon MC (2014) Experimental autoimmune myasthenia gravis (EAMG): from immunochemical characterization to therapeutic approaches. J Autoimmun 54:51–59
31. Gershwin ME, Krawitt EL (2014) Autoimmune hepatitis: 50 years of (slow) progress. Hepatology 59:754–756
32. Huang W, Kachapati K, Adams D et al (2014) Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells. J Autoimmun 50:123–134
33. Hudspeth K, Pontarini E, Tentorio P et al (2013) The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun 46:55–65
34. Kar SP, Seldin MF, Chen W et al (2013) Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. Genes Immun 14:179–186
35. Kawata K, Tsuda M, Yang GX et al (2013) Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis. PLoS One 8:e74225
36. Kawata K, Yang GX, Ando Y et al (2013) Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice. Hepatology 58:1094–1104
37. Kurth MJ, Yokoi T, Gershwin ME (2014) Halothane-induced hepatitis: paradigm or paradox for drug-induced liver injury. Hepatology 60:1473–1475
38. Lleo A, Oertelt-Prigione S, Bianchi I et al (2013) Y chromosome loss in male patients with primary biliary cirrhosis. J Autoimmun 41:87–91
39. Lleo A, Zhang W, McDonald WH et al (2014) Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology 60:1314–1323
40. Mayer CT, Ghorbani P, Kuhl AA et al (2014) Few Foxp3(+) regulatory T cells are sufficient to protect adult mice from lethal autoimmunity. Eur J Immunol 44:2990–3002
41. Ridgway WM, Gershwin ME (2014) Prometheus unbound: NKT cells inhibit hepatic regeneration. Hepatology 60:1133–1135
42. Selmi C, Cavaciocchi F, Lleo A et al (2014) Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis. Front Immunol 5:128
43. Sthoeger Z, Sharabi A, Mozes E (2014) Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus. J Autoimmun 54:60–71
44. Tanaka H, Yang GX, Iwakoshi N et al (2013) Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol 174:364–371
45. Tanaka H, Zhang W, Yang GX et al (2014) Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells. Clin Exp Immunol 178:253–261
46. Wang J, Budamagunta MS, Voss JC et al (2013) Antimitochondrial antibody recognition and structural integrity of the inner lipoyl domain of the E2 subunit of pyruvate dehydrogenase complex. J Immunol 191:2126–2133
47. Wang J, Yang GX, Tsuneyama K, Gershwin ME, Ridgway WM, Leung PS (2014) Animal models of primary biliary cirrhosis. Semin Liver Dis 34:285–296
48. Wang L, Sun Y, Zhang Z et al (2015) CXCR5(+) CD4(+) T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology 61:627–638
49. Xu X, Zhang S, Jin R et al (2015) Retention and tolerance of autoreactive CD4(+) recent thymic emigrants in the liver. J Autoimmun 56:87–97
50. Yang CY, Ma X, Tsuneyama K et al (2014) IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 59:1944–1953
51. Yao Y, Yang W, Yang YQ et al (2014) Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha(−/−) mice. J Autoimmun 51:99–108
52. Zhang J, Zhang W, Leung PS et al (2014) Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 60:1708–1716
53. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ (2009) Primary biliary cirrhosis. Hepatology 50:291–308
54. European Association for the Study of the Liver (2009) EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 51:237–267
55. Boonstra K, Beuers U, Ponsioen CY (2012) Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 56:1181–1188
56. Hirschfield G M, Siminovitch K A, (2014) Genetics in PBC: what do the “risk genes” teach us? Clin Rev Allergy Immunol
57. Dong M, Li J, Tang R, et al (2015) Multiple genetic variants associated with primary biliary Cirrhosis in a Han Chinese Population. Clin Rev Allergy Immunol
58. Gershwin ME, Mackay IR (2008) The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47:737–745
59. Beuers U, Hohenester S, de Buy Wenniger LJ, Kremer AE, Jansen PL, Elferink RP (2010) The biliary HCO(3)(−) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 52:1489–1496
60. Medina JF, Martinez A, Vazquez JJ, Prieto J (1997) Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 25:12–17
61. Liaskou E, Hirschfield GM, Gershwin ME (2014) Mechanisms of tissue injury in autoimmune liver diseases. Semin Immunopathol 36:553–568
62. Pollheimer M J, Fickert P, (2014) Animal models in primary biliary cirrhosis and primary sclerosing cholangitis. Clin Rev Allergy Immunol
63. Floreani A, Spinazze A, Caballeria L, et al (2014) Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers. Clin Rev Allergy Immunol
64. Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin M E, (2015) The coexistence of sjogren’s syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol
65. Sun Y, Haapanen K, Li B, Zhang W, Van de Water J, Gershwin, M E (2014) Women and primary biliary cirrhosis. Clin Rev Allergy Immunol
66. Floreani A, Infantolino C, Franceschet I, et al (2014) Pregnancy and primary biliary cirrhosis: a case–control study. Clin Rev Allergy Immunol
67. Corpechot C, Abenavoli L, Rabahi N et al (2008) Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 48:871–877
68. Corpechot C, Chazouilleres O, Poupon R (2011) Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol 55:1361–1367
69. Lammers WJ, van Buuren HR, Hirschfield GM et al (2014) Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology 147:1338–1349.e5, quiz e1315
70. Pares A, Caballeria L, Rodes J (2006) Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology 130:715–720
71. Floreani A, Franceschet I, Perini L, Cazzagon N, Gershwin M E, Bowlus C L, (2014) New therapies for primary biliary cirrhosis. Clin Rev Allergy Immunol
72. Dyson J K, Hirschfield G M, Adams D H, et al (2015) Novel therapeutic targets in primary biliary cirrhosis. Nat Rev Gastroenterol Hepatol
73. Beuers U, Trauner M, Jansen P, Poupon R (2015) New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatology 62, in press
74. Griffiths L, Jones DE (2014) Pathogenesis of primary biliary cirrhosis and its fatigue. Dig Dis 32:615–625
75. Beuers U, Kremer AE, Bolier R, Elferink RP (2014) Pruritus in cholestasis: facts and fiction. Hepatology 60:399–407
76. Folseraas T, Liaskou E, Anderson C A, Karlsen T H (2014) Genetics in PSC: What do the “risk genes” teach us? Clin Rev Allergy Immunol
77. Karlsen TH, Franke A, Melum E et al (2010) Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 138:1102–1111
78. Folseraas T, Melum E, Rausch P et al (2012) Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J Hepatol 57:366–375
79. Maroni L, van de Graaf S F, Hohenester S D, Oude Elferink R P, Beuers U (2014) Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and crohn’s disease-a comprehensive review. Clin Rev Allergy Immunol
80. Keitel V, Reich M, Haussinger D (2014) TGR5: pathogenetic role and/or therapeutic target in fibrosing cholangitis? Clin Rev Allergy Immunol
81. Hohenester S, Wenniger LM, Paulusma CC et al (2012) A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology 55:173–183
82. Fickert P, Pollheimer MJ, Beuers U et al (2014) Characterization of animal models for primary sclerosing cholangitis (PSC). J Hepatol 60:1290–1303
83. Liaskou E, Jeffery LE, Trivedi PJ et al (2014) Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. Gastroenterology 147(221–232):e227
84. Chapman R, Fevery J, Kalloo A et al (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51:660–678
85. Hubers L M, Maillette de Buy Wenniger L J, Doorenspleet M E, et al (2014) IgG4-associated cholangitis: a comprehensive review. Clin Rev Allergy Immunol
86. de Buy M, Wenniger LJ, Doorenspleet ME, Klarenbeek PL et al (2013) Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology 57:2390–2398
87. Wallace ZS, Mattoo H, Carruthers M et al (2015) Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 74:190–195
88. de Buy Wenniger LJ, Culver EL, Beuers U (2014) Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology 60:1453–1454
89. Ghazale A, Chari ST, Zhang L et al (2008) Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 134:706–715
90. Gong YZ, Nititham J, Taylor K et al (2014) Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjogren’s syndrome. J Autoimmun 51:57–66
91. Invernizzi P, Gershwin ME (2014) New therapeutics in primary biliary cirrhosis: will there ever be light? Liver Int 34:167–170
92. Seror R, Theander E, Bootsma H et al (2014) Outcome measures for primary Sjogren’s syndrome: a comprehensive review. J Autoimmun 51:51–56